Published in J Neurol Neurosurg Psychiatry on December 01, 1988
Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord (2008) 1.44
Effects of Parkinson's disease on visuomotor adaptation. Exp Brain Res (2003) 1.28
Basal ganglia-dependent processes in recalling learned visual-motor adaptations. Exp Brain Res (2011) 1.12
Podokinetic after-rotation in Parkinson disease. Brain Res (2006) 1.04
Acquisition of internal models of motor tasks in children with autism. Brain (2008) 1.01
Visuomotor learning in immersive 3D virtual reality in Parkinson's disease and in aging. Exp Brain Res (2006) 0.95
Formation of a long-term memory for visuomotor adaptation following only a few trials of practice. J Neurophysiol (2015) 0.93
Effects of dopaminergic therapy on locomotor adaptation and adaptive learning in persons with Parkinson's disease. Behav Brain Res (2014) 0.91
Dopaminergic striatal innervation predicts interlimb transfer of a visuomotor skill. J Neurosci (2011) 0.85
Sensorimotor adaptation of speech in Parkinson's disease. Mov Disord (2013) 0.83
Prism adaptation in Parkinson disease: comparing reaching to walking and freezers to non-freezers. Exp Brain Res (2015) 0.81
Curved Walking Rehabilitation with a Rotating Treadmill in Patients with Parkinson's Disease: A Proof of Concept. Front Neurol (2017) 0.75
The many facets of motor learning and their relevance for Parkinson's disease. Clin Neurophysiol (2017) 0.75
Cognitive deficits in the early stages of Parkinson's disease. Brain (1983) 2.65
Initiation and execution of predictable and unpredictable movements in Parkinson's disease. Brain (1984) 2.27
PLASTICITY IN HUMAN SENSORIMOTOR CONTROL. Science (1963) 1.94
Lack of prediction in the motor behaviour of Parkinsonism. Brain (1978) 1.92
Adaptation to lateral displacement of vision in patients with lesions of the central nervous system. Neurology (1983) 1.72
The effect of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry (1985) 1.59
Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry (1983) 1.44
The caudate nucleus egocentric localization system. Acta Neurobiol Exp (Wars) (1972) 1.12
Efference copy in the control of movement. Neurology (1976) 0.97
Visuo-motor adaptation (to prismatic transformation of the retinal image) in monkeys with bilateral dorsal rhizotomy. Brain (1968) 0.86
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Influence of education and occupation on the incidence of Alzheimer's disease. JAMA (1994) 8.43
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol (2001) 3.43
Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry (1996) 2.99
Depression, intellectual impairment, and Parkinson disease. Neurology (1981) 2.96
Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A (1995) 2.92
Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry (1999) 2.92
Internal effects of divalent cations on potassium permeability in molluscan neurones. J Physiol (1979) 2.81
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80
Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol (1992) 2.59
Effects of 4-aminopyridine on potassium currents in a molluscan neuron. J Gen Physiol (1981) 2.35
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet (1994) 2.24
Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology (1995) 2.24
Smoking and Parkinson's disease in twins. Neurology (2002) 2.15
The influence of smoking on the risk of Alzheimer's disease. Neurology (1999) 2.14
Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol (1999) 2.13
The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology (2003) 2.11
Role of RNA transcripts in replication incompatibility and copy number control in antibiotic resistance plasmid derivatives. Nature (1981) 2.05
Genes and sites involved in replication and incompatibility of an R100 plasmid derivative based on nucleotide sequence analysis. Mol Gen Genet (1980) 1.98
Effects of tetraethylammonium on potassium currents in a molluscan neurons. J Gen Physiol (1981) 1.98
Blockade of voltage-dependent and Ca2+-dependent K+ current components by internal Ba2+ in molluscan pacemaker neurons. Experientia (1979) 1.93
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol (2011) 1.90
Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci U S A (1989) 1.89
A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (1998) 1.86
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry (1998) 1.85
Charybdotoxin selectively blocks small Ca-activated K channels in Aplysia neurons. J Gen Physiol (1987) 1.85
Is "subcortical dementia" a recognizable clinical entity? Ann Neurol (1983) 1.85
Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol (1995) 1.85
Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology (1995) 1.84
A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA (2001) 1.82
Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology (1985) 1.81
Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood (1994) 1.78
The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology (2002) 1.77
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci U S A (1992) 1.77
Antecedent clinical features associated with dementia in Parkinson's disease. Neurology (1993) 1.74
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS (1990) 1.71
Predictors of disease course in patients with probable Alzheimer's disease. Neurology (1987) 1.66
Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology (2001) 1.64
Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61
Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA (1997) 1.61
Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol (1995) 1.58
Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry (1995) 1.57
Decline in cognitive and functional skills increases mortality risk in nondemented elderly. Neurology (2005) 1.56
Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Arch Neurol (2000) 1.55
The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology (1994) 1.54
Alzheimer's disease after remote head injury: an incidence study. J Neurol Neurosurg Psychiatry (1997) 1.53
Memory performance is related to amyloid and tau pathology in the hippocampus. J Neurol Neurosurg Psychiatry (2009) 1.52
Site specific recombination involved in the generation of small plasmids. Mol Gen Genet (1978) 1.52
The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol (1995) 1.51
Specificity of the fivefold increase in AD in mothers of adults with Down syndrome. Neurology (2001) 1.50
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection. J Clin Microbiol (1987) 1.49
Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology (1999) 1.48
The Columbia University Scale for Psychopathology in Alzheimer's disease. Arch Neurol (1992) 1.48
Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis. Arch Neurol (1992) 1.47
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol (1987) 1.47
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology (1981) 1.46
Localization of postsynaptic density-93 to dendritic microtubules and interaction with microtubule-associated protein 1A. J Neurosci (1998) 1.46
Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord (1994) 1.46
Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology (2005) 1.45
Ionic requirements for membrane oscillations and their dependence on the calcium concentration in a molluscan pace-maker neurone. J Physiol (1982) 1.45
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med (1993) 1.45
Association between genetic variants in SORL1 and autopsy-confirmed Alzheimer disease. Neurology (2007) 1.45
Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia (2008) 1.45
Validity of family history for the diagnosis of dementia among siblings of patients with late-onset Alzheimer's disease. Genet Epidemiol (1998) 1.45
The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study. J Am Geriatr Soc (2000) 1.44
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology (1999) 1.44
Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry (1983) 1.44
Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA (1999) 1.42
Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology (1994) 1.39
Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA (1997) 1.38
Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci U S A (1997) 1.36
Selective decline in memory function among healthy elderly. Neurology (1999) 1.36
Plasma homocysteine levels and risk of Alzheimer disease. Neurology (2004) 1.36
An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol (1992) 1.34
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris) (2013) 1.33
Effect of route on inoculation on host resistance to Nocardia. Infect Immun (1980) 1.32
Measurement and prediction of functional capacity in Alzheimer's disease. Neurology (1990) 1.31
Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology (1996) 1.30
Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology (2005) 1.30
Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet (1996) 1.30
Autoantibodies to amyloid-beta and Alzheimer's disease. Ann Neurol (2001) 1.28
Subclinical cerebrovascular disease in mild cognitive impairment. Neurology (2009) 1.28
A brain imaging (single photon emission computerized tomography) study of semantic and affective processing in psychopaths. Biol Psychiatry (1997) 1.27
Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids. Nature (1984) 1.26
Mechanisms of L-cysteine neurotoxicity. Neurochem Res (2000) 1.25
A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol (1999) 1.25